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INITIAL EVALUATION AND OUTPATIENT MANAGEMENT 
DURING THE FIRST 12 MONTHS OF LIFE FOR INFANTS WITH 
POSSIBLE CONGENITAL ZIKA VIRUS INFECTION
Does mother have 
lab evidence of Zika 
virus infection?*
YES
Does infant have 
abnormalities consistent 






 £ Routine newborn 
care: physical exam, 
including head 
circumference, 
weight, length and 
neuro exam
 £ Head ultrasound 
 £ Infant testing for 
congenital Zika  
virus infection  
(See Table 1)
 £ Consider transfer 
to hospital with 
subspecialty care
 £ CBC, metabolic 
panel, LFTs 
 £ Ophthalmology 
exam 
 £ ABR
 £ Consider further 
neuroimaging 
 £ Consult with 
multiple specialists
(See Page 3, Checklist 1)
Does infant have 








 £ Routine newborn care: physical exam, 
including head circumference, weight, 
length and neuro exam
 £ Standard newborn hearing screen
 £ Head ultrasound 
 £ Infant testing for congenital Zika virus 
infection (See Table 1)
Does infant have 






MOTHER NOT TESTED, OR TESTED 
OUTSIDE OF APPROPRIATE WINDOW§
Does infant have 
abnormalities consistent 




 £ Maternal Zika virus 
testing §
 £ Consider Zika 
virus testing of the 
placenta 





weight, length and 
neuro exam 
 £ Head ultrasound
 £ Infant testing for 
congenital Zika 
virus infection                
(See Table 1) 
 £ Consider transfer 
to hospital with 
subspecialty care
 £ CBC, metabolic 
panel, LFTs 
 £ Ophthalmology 
exam 
 £ ABR
 £ Consider further 
neuroimaging
 £ Consult with 
multiple specialists
Does infant have 








 £ Maternal Zika virus testing § 
 £ Consider Zika virus testing of the  
placenta
 £ Routine newborn care: physical exam, 
including head circumference, weight, 
length and neuro exam 
 £ Standard newborn hearing screen 
 £ Head ultrasound 
Perform infant Zika virus testing if evidence of 
Zika virus infection on maternal testing §*‡
Does infant have 






Follow management and follow-up recommendations indicated in Outpatient Management Checklist 
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laboratory evidence of 
Zika virus infection*
 £Thyroid screen 
(TSH & T4)








 £Routine preventive health care including monitoring of feeding and growth
 £Routine and congenital infection-specific anticipatory guidance
 £Referral to specialists, including evaluation of other causes of congenital anomalies as needed 
 £Referral to early intervention services 





syndrome† and negative 
for Zika virus infection
 £Continue to evaluate for other causes of congenital anomalies
 £Further management as clinically indicated




syndrome† and  










ABR not done 
at 4-6 months
 £Monitoring of growth parameters (HC, weight, and height), developmental monitoring by caregivers and health care providers,  
and age-appropriate developmental screening at well-child visits (See Page 3, Checklist 3)             




syndrome† and negative 
for Zika virus infection
 £Monitoring of growth parameters (HC, weight, and height), developmental monitoring by caregivers and health care providers,  
and age-appropriate developmental screening at well-child visits
Abbreviations: rRT-PCR = real-time reverse transcription–polymerase chain reaction; IgM = immunoglobulin M; CBC = complete blood count; LFTs = liver function tests, PE = physical examination; US = ultrasound; 
ABR = auditory brainstem response; CT = computed tomography; MRI = magnetic resonance imaging;  neuro = neurologic;  HC = Head (occipitofrontal) circumference
* Laboratory evidence of Zika virus infection includes: (1) Zika virus RNA detected by real-time reverse transcription-polymerase chain reaction (rRT-PCR) in any clinical specimen; or (2) positive Zika virus IgM. 
Confirmatory neutralizing antibody titers are needed in addition to IgM for maternal Zika virus infection. Cord blood and testing of the placenta not recommended for infant testing for Zika virus.
** Outpatient management checklist for infants born to a woman with laboratory evidence of confirmed or possible Zika virus infection.
† Findings consistent with congenital Zika virus syndrome can include microcephaly, intracranial calcifications, or other brain or eye abnormalities.
§  Mothers who travelled to or reside in an area of active Zika transmission or who had unprotected sex with a partner who had traveled to or resided in an area with active transmission should be tested by rRT-PCR 
within 2 weeks of exposure or symptom onset, or IgM within 2-12 weeks of exposure or symptom onset. Because of the decline in IgM antibody and viral RNA levels over time, negative maternal testing 12 weeks 
after exposure or symptom onset does not rule out maternal infection.
‡ Infant testing is recommended within the first two days after birth; if testing is performed later, it can be difficult to distinguish congenital infection from perinatally or postnatally acquired infection. 
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TABLE 1
Interpretation of results of laboratory testing of infant’s blood, urine and/or cerebrospinal fluid for evidence of congenital Zika virus infection 
Infant test results* Interpretation 
rRT-PCR IgM
Positive Positive or Negative Confirmed congenital Zika virus infection 
Negative Positive Probable congenital Zika virus infection+
Negative Negative Negative for congenital Zika virus infection+
Abbreviations: rRT-PCR = real-time reverse transcription-polymerase chain reaction; IgM = Immunoglobulin M 
* Infant serum, urine or cerebrospinal fluid.
+ Laboratory results should be interpreted in the context of timing of infection during pregnancy, maternal serology results, clinical 
findings consistent with congenital Zika syndrome, and any confirmatory testing with plaque reduction neutralization testing (PRNT).
CHECKLIST 1
Initial clinical evaluation & management of infants 
with laboratory evidence of Zika virus infection 
and abnormalities consistent with congenital 
Zika syndrome †
Consultation with: 
 £ Neurologist for determination of appropriate  neuroimaging  
and additional evaluation.
 £ Infectious disease specialist for diagnostic evaluation of other 
congenital infections (e.g. syphilis, toxoplasmosis, rubella, 
cytomegalovirus infection, lymphocytic choriomeningitis virus 
infection, and herpes simplex virus infection).
 £ Ophthalmologist for comprehensive eye exam and evaluation 
for possible cortical visual impairment prior to discharge from 
hospital or within 1 month of birth.
 £ Endocrinologist for evaluation for hypothalamic or pituitary 
dysfunction.
 £ Clinical geneticist to evaluate for other causes of 
microcephaly or other anomalies if present.
Consider consultation with:
 £ Orthopedist, physiatrist and physical therapist for the 
management of hypertonia, club foot or arthrogrypotic-like 
conditions.
 £ Pulmonologist or otolaryngologist for concerns about aspiration.
 £ Lactation specialist, nutritionist, gastroenterologist, or speech or 
occupational therapist for the management of feeding issues.
 £ Perform ABR to assess hearing.
 £ Perform complete blood count and metabolic panel, including 
liver function tests.
 £ Provide family and supportive services.
CHECKLIST 2
Outpatient management of infants with laboratory 
evidence of Zika virus infection and abnormalities 
consistent with congenital Zika syndrome †
 £ A medical home should be established, and visits with primary 
care provider should occur monthly for at least the first 6 months 
of life.
 £ Follow growth parameters, monitor development, encourage 
parents and other caregivers to monitor child’s development, 
provide routine immunizations and anticipatory guidance, 
psychosocial support, and to ensure infants receive 
necessary testing and consultations.
 £ Neurologic examination by the primary care provider at 1 and 2 
months of age. Refer to neurology for any abnormalities, or for 
any parental or provider concerns. 
 £ Refer to developmental specialist and early intervention services.
 £ Repeat a comprehensive ophthalmologic exam at 3 months of 
age, and refer to ophthalmology for any abnormal findings, or for 
any parental or provider concerns. 
 £ Repeat ABR testing at 4-6 months of age, and follow up on any 
abnormal findings, or for any parental or provider concerns. 
 £ Repeat testing for hypothyroidism (i.e. TSH, total T4 and 
estimated free T4) at 2 weeks and 3 months of age, even if 
the initial testing was normal. Refer to endocrinology for any 
abnormal findings.
 £ Provide family and supportive services.
CHECKLIST 3
Outpatient management of infants with 
laboratory evidence of Zika virus infection, but 
without abnormalities consistent with congenital 
Zika syndrome †
 £ A medical home should be established.
 £ Follow growth parameters, perform developmental monitoring 
at each well child visit and encourage parents and other 
caregivers to monitor child’s development. 
 £ Emphasize anticipatory guidance for families regarding 
developmental milestones, feeding and growth, sleep and 
irritability, and abnormal movements.
 £ Use a standardized, validated developmental screening tool at 9 
months as currently recommended, or earlier for any parental or 
provider concerns. 
 £ Referral to ophthalmology for comprehensive eye exam within 
one month of birth. Perform vision screening and assess visual 
regard at every well child visit, and refer to ophthalmology for 
any abnormal findings, or for any parental or provider concerns.
 £ Perform ABR within one month of birth. Perform behavioral 
diagnostic testing at 9 months of age, or consider repeat ABR at 
4–6 months. Refer to audiology for any abnormal findings, or for 
any parental or provider concerns. 
 £ Provide family and supportive services.
